Chromatin-modifying enzymes as therapeutic targets – Part 2
نویسندگان
چکیده
منابع مشابه
Proteolytic Enzymes as Therapeutic Targets
treat acquired immunodeficiency syndrome [AIDS]) and against the angiotensin-converting enzyme (ACE) (to treat hypertension) are the only protease inhibitors approved by the FDA for therapeutic use (see Table 1). HIV-1 protease is an aspartic protease that is necessary for the processing of viral polypeptides late in the viral replicative cycle. Inhibition of this activity prevents formation of...
متن کاملChromatin regulation in schistosomes and histone modifying enzymes as drug targets.
Only one drug is currently available for the treatment and control of schistosomiasis and the increasing risk of selecting strains of schistosome that are resistant to praziquantel means that the development of new drugs is urgent. With this objective we have chosen to target the enzymes modifying histones and in particular the histone acetyltransferases and histone deacetylases (HDAC). Inhibit...
متن کاملHuman isoprenoid synthase enzymes as therapeutic targets
In the human body, the complex biochemical network known as the mevalonate pathway is responsible for the biosynthesis of all isoprenoids, which consists of a vast array of metabolites that are vital for proper cellular functions. Two key isoprenoids, farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) are responsible for the post-translational prenylation of small GTP-binding ...
متن کاملNew Nomenclature for Chromatin-Modifying Enzymes
In the last ten years, the importance of chromatin modifications in many aspects of biology has become apparent. Several families of enzymes that modify histones have been identified, the majority of which are conserved throughout evolution. The enormous interest in this field has resulted in a very rapid rate of discovery of new enzymes, but this in turn has lead to a noncoherent nomenclature ...
متن کاملChromatin-modifying enzymes in transcription and cancer
In recent years, our view of how gene expression is controlled has changed dramatically. The discovery of enzymes that modify histones has revealed that transcription is an enzymically driven process. Such modifications can recruit specific proteins and mediate chromatin changes that affect transcription either positively or negatively. Important biological pathways leading to cell proliferatio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Opinion on Therapeutic Targets
سال: 2008
ISSN: 1472-8222,1744-7631
DOI: 10.1517/14728222.12.11.1457